315 related articles for article (PubMed ID: 16019692)
21. Antibiotic therapy for trachoma.
Prescrire Int; 2009 Aug; 18(102):176-7. PubMed ID: 19750586
[TBL] [Abstract][Full Text] [Related]
22. Global burden of trachoma and economics of the disease.
Frick KD; Hanson CL; Jacobson GA
Am J Trop Med Hyg; 2003 Nov; 69(5 Suppl):1-10. PubMed ID: 14692674
[TBL] [Abstract][Full Text] [Related]
23. Trachoma and antibiotic use: the 'A' in SAFE.
West S
Expert Rev Anti Infect Ther; 2012 Jan; 10(1):75-83. PubMed ID: 22149616
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for postsurgical trichiasis recurrence in a trachoma-endemic area.
West ES; Mkocha H; Munoz B; Mabey D; Foster A; Bailey R; West SK
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):447-53. PubMed ID: 15671268
[TBL] [Abstract][Full Text] [Related]
25. New steps toward eliminating blinding trachoma.
Mariotti SP
N Engl J Med; 2004 Nov; 351(19):2004-7. PubMed ID: 15525727
[No Abstract] [Full Text] [Related]
26. Single-dose azithromycin prevents trichiasis recurrence following surgery: randomized trial in Ethiopia.
West SK; West ES; Alemayehu W; Melese M; Munoz B; Imeru A; Worku A; Gaydos C; Meinert CL; Quinn T
Arch Ophthalmol; 2006 Mar; 124(3):309-14. PubMed ID: 16534049
[TBL] [Abstract][Full Text] [Related]
27. Impact of oral azithromycin on recurrence of trachomatous trichiasis in Nepal over 1 year.
Zhang H; Kandel RP; Atakari HK; Dean D
Br J Ophthalmol; 2006 Aug; 90(8):943-8. PubMed ID: 16687452
[TBL] [Abstract][Full Text] [Related]
28. Blinding trachoma in katsina state, Nigeria: population-based prevalence survey in ten local government areas.
Jip NF; King JD; Diallo MO; Miri ES; Hamza AT; Ngondi J; Emerson PM
Ophthalmic Epidemiol; 2008; 15(5):294-302. PubMed ID: 18850465
[TBL] [Abstract][Full Text] [Related]
29. Mathematical models of cervical cancer prevention in the Asia Pacific region.
Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ
Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411
[TBL] [Abstract][Full Text] [Related]
30. Household willingness to pay for azithromycin treatment for trachoma control in the United Republic of Tanzania.
Frick KD; Lynch M; West S; Munoz B; Mkocha HA
Bull World Health Organ; 2003; 81(2):101-7. PubMed ID: 12751418
[TBL] [Abstract][Full Text] [Related]
31. A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia.
Burton MJ; Kinteh F; Jallow O; Sillah A; Bah M; Faye M; Aryee EA; Ikumapayi UN; Alexander ND; Adegbola RA; Faal H; Mabey DC; Foster A; Johnson GJ; Bailey RL
Br J Ophthalmol; 2005 Oct; 89(10):1282-8. PubMed ID: 16170117
[TBL] [Abstract][Full Text] [Related]
32. Mapping trachoma in Nasarawa and Plateau States, central Nigeria.
King JD; Jip N; Jugu YS; Othman A; Rodgers AF; Dajom DY; Miri E; Emerson PM
Br J Ophthalmol; 2010 Jan; 94(1):14-9. PubMed ID: 20385526
[TBL] [Abstract][Full Text] [Related]
33. Estimating the Future Impact of a Multi-Pronged Intervention Strategy on Ocular Disease Sequelae Caused by Trachoma: A Modeling Study.
Gambhir M; Grassly NC; Burton MJ; Solomon AW; Taylor HR; Mabey DC; Blake IM; Basáñez MG
Ophthalmic Epidemiol; 2015; 22(6):394-402. PubMed ID: 26653262
[TBL] [Abstract][Full Text] [Related]
34. Trachoma: new assault on an ancient disease.
West SK
Prog Retin Eye Res; 2004 Jul; 23(4):381-401. PubMed ID: 15219874
[TBL] [Abstract][Full Text] [Related]
35. [Trachoma in Chad: results of an epidemiological survey].
Madani MO; Huguet P; Mariotti SP; Dézoumbé D; Tosi C; Djada D; Negrel AD
Sante; 2003; 13(1):9-15. PubMed ID: 12925317
[TBL] [Abstract][Full Text] [Related]
36. Preventing trachoma through environmental sanitation: a review of the evidence base.
Prüss A; Mariotti SP
Bull World Health Organ; 2000; 78(2):258-66. PubMed ID: 10743299
[TBL] [Abstract][Full Text] [Related]
37. Global elimination of trachoma: how frequently should we administer mass chemotherapy?
Lietman T; Porco T; Dawson C; Blower S
Nat Med; 1999 May; 5(5):572-6. PubMed ID: 10229236
[TBL] [Abstract][Full Text] [Related]
38. Complete elimination is a difficult goal for trachoma programs in severely affected communities.
Gill DA; Lakew T; Alemayehu W; Melese M; Zhou Z; House JI; Hong KC; Ray KJ; Gandhi N; Whitcher JP; Gaynor BD; Lietman TM
Clin Infect Dis; 2008 Feb; 46(4):564-6. PubMed ID: 18194094
[TBL] [Abstract][Full Text] [Related]
39. The SAFE strategy for trachoma control: planning a cost-effectiveness analysis of the antibiotic component and beyond.
Frick KD; West SK
Ophthalmic Epidemiol; 2001 Sep; 8(4):205-14. PubMed ID: 11471089
[TBL] [Abstract][Full Text] [Related]
40. The costs and cost-effectiveness of an integrated sepsis treatment protocol.
Talmor D; Greenberg D; Howell MD; Lisbon A; Novack V; Shapiro N
Crit Care Med; 2008 Apr; 36(4):1168-74. PubMed ID: 18379243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
